• LAST PRICE
    19.1700
  • TODAY'S CHANGE (%)
    Trending Up0.2400 (1.2678%)
  • Bid / Lots
    19.1600/ 1
  • Ask / Lots
    19.2700/ 8
  • Open / Previous Close
    19.4100 / 18.9300
  • Day Range
    Low 19.1100
    High 19.7500
  • 52 Week Range
    Low 11.1200
    High 21.1000
  • Volume
    131,656
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Wednesday's close: 18.93
TimeVolumeTCMD
09:32 ET1789219.3481
09:33 ET472819.355
09:35 ET321419.38
09:37 ET370619.34
09:39 ET493119.24
09:42 ET519219.5599
09:44 ET1139019.545
09:46 ET158019.51
09:48 ET70019.6
09:50 ET227519.665
09:51 ET434119.6
09:55 ET159719.63
09:57 ET110019.69
10:00 ET122919.68
10:02 ET60619.68
10:04 ET233019.59
10:06 ET217319.48
10:08 ET155319.38
10:09 ET741719.18
10:11 ET650319.25
10:13 ET105019.235
10:15 ET110019.28
10:18 ET406919.25
10:20 ET60019.3225
10:22 ET306519.1875
10:24 ET100019.17
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesTCMD
Tactile Systems Technology Inc
454.3M
29.8x
+29.16%
United StatesTMCI
Treace Medical Concepts Inc
515.8M
-8.7x
---
United StatesANGO
AngioDynamics Inc
284.0M
-1.2x
---
United StatesCERS
Cerus Corp
338.0M
-16.8x
---
United StatesZIMV
ZimVie Inc
400.7M
-8.3x
---
United StatesSIBN
SI-BONE Inc
556.5M
-15.0x
---
As of 2024-11-29

Company Information

Tactile Systems Technology, Inc., doing business as Tactile Medical, is a medical technology company providing therapies for people with chronic disorders. The Company's areas of therapeutic focus are vascular disease, oncology and providing airway clearance therapy for those suffering from chronic respiratory conditions. It is developing and marketing at-home therapies for people suffering from underserved, chronic conditions including lymphedema, lipedema, chronic venous insufficiency and chronic pulmonary disease. It markets Flexitouch Plus and Entre Plus systems as at-home therapies for the treatment of lymphedema and chronic venous insufficiency. The Company markets AffloVest as an at-home therapy intended to promote airway clearance. Its Flexitouch Plus system is a fully automated, programmable, advanced pneumatic compression device. The Company's Entre system is a basic pneumatic compression device. Kylee, its free mobile application, helps patients learn about lymphedema.

Contact Information

Headquarters
1331 Tyler St NE Ste 200MINNEAPOLIS, MN, United States 55413-1638
Phone
612-355-5100
Fax
612-355-5101

Executives

Independent Chairman of the Board
William Burke
Chief Executive Officer, Director
Sheri Dodd
Chief Financial Officer
Elaine Birkemeyer
Senior Vice President - Sales
Sherri Ferstler
Senior Vice President - Marketing and Clinical Affairs
Kristie Burns

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$454.3M
Revenue (TTM)
$285.1M
Shares Outstanding
24.0M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
1.18
EPS
$0.64
Book Value
$8.20
P/E Ratio
29.8x
Price/Sales (TTM)
1.6
Price/Cash Flow (TTM)
20.5x
Operating Margin
7.53%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.